A detailed history of Cwc Advisors, Llc. transactions in Haemonetics Corp stock. As of the latest transaction made, Cwc Advisors, Llc. holds 3,083 shares of HAE stock, worth $197,312. This represents 0.24% of its overall portfolio holdings.

Number of Shares
3,083
Previous 2,871 7.38%
Holding current value
$197,312
Previous $231 Million 4.31%
% of portfolio
0.24%
Previous 0.23%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Mar 18, 2025

BUY
$71.16 - $93.38 $15,085 - $19,796
212 Added 7.38%
3,083 $241 Million
Q3 2024

Oct 23, 2024

BUY
$72.45 - $91.58 $208,003 - $262,926
2,871 New
2,871 $231 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.28B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Cwc Advisors, Llc. Portfolio

Follow Cwc Advisors, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwc Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Cwc Advisors, Llc. with notifications on news.